Multicenter retrospective evaluation of predictive and prognostic factors in radiochemo-/radiotherapy of anaplastic thyroid cancer

Multicenter retrospective evaluation of predictive and prognostic factors in radiochemo-/radiotherapy of anaplastic thyroid cancer - ATC study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032180

Enrollment

270

Registered

2023-07-24

Start date

2020-03-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ORPHA:142 C73

Interventions

Group 1: Retrospective analysis of all patients treated with radiochemo-/radiotherapy for anaplastic thyroid cancer (ATC) in the participating cancer centers between 2000 and 2020

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study will include patients who have been diagnosed with anaplastic thyroid carcinoma stage IV (classification of tumor stages according to classification of tumor stages according to UICC) and who have been treated at the Department of Radiation Oncology of the University of Munich or the participating centers, have been diagnosed since 01/2000 and treated with curative or palliative intent. The treatment includes both radio- as well as radiochemotherapy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Overall survival with identification of predictive and prognostic factors	—

Secondary

Measure	Time frame
treatment-related toxicity progression-free survival (PFS) distant control	—

Countries

Germany

Contacts

Public ContactLukas Käsmann

Klinik für Strahlentherapie, LMU Klinikum

lukas.kaesmann@med.uni-muenchen.de*49 89440074511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026